# Ofev®抑肺纖®

Treatment of patients with idiopathic pulmonary fibrosis(IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and Progressive Fibrosing-Interstitial Lung Disease (PF-ILD)

點擊放大

## Product Key Facts

[中文仿單](/content/tw/disclaimer/external?path=https%3A%2F%2Flmspiq.fda.gov.tw%2Fweb%2FDRPIQ%2FDRPIQ1000Result%3FlicBaseId%3D2772A2A2-1C36-449E-B0DC-308FDA870DE5/index.html)

Ofev®

nintedanib esylate

##### 透過新聞瞭解更多資訊，請見【 [肺纖維化](/content/tw/renleichufangyongyao/feibujibing/feixianweihua/index.html)】【 [硬皮病](/content/tw/renleichufangyongyao/feibujibing/yingpibing/index.html)】頁面

### References